NeuroPsyCAD
NeuroPsyCAD provides clinicians with patient-personalized reports for early and accurate diagnoses of neuropsychiatric disorders.
NeuroPsyCAD is a business in analytics, health care, hospital, neuroscience based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2017.
Within the analytics, health care, hospital, neuroscience space, the company focuses on its core offering rather than a broad product line.
The business is associated with European Union (EU), Europe, Middle East, and Africa (EMEA).
It is recorded at the Grant stage.
Its team size is recorded as c_00101_00250 employees.
It has disclosed roughly $5K in funding.
| Sector | Analytics, Health Care, Hospital, Neuroscience |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2017 |
| Employees | c_00101_00250 |
| Stage | grant |
| Total funding | $50,000 |
Website: neuropsycad.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account